|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 487/04 | |
| A61K 31/4985 | |||
| A61K 31/519 | |||
| A61P 25/00 |
| (11) | Patento numeris | 3288945 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16721038.4 |
| Europos patento paraiškos padavimo data | 2016-04-28 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-03-07 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-09-18 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2016/029791 |
| Data | 2016-04-28 |
| (87) | Numeris | WO 2016/176457 |
| Data | 2016-11-03 |
| (30) | Numeris | Data | Šalis |
| 201562154310 P | 2015-04-29 | US |
| (72) |
SAVALL, Bradley M., US
SWANSON, Devin M., US
WU, Dongpei, US
AMERIKS, Michael K., US
|
| (73) |
Janssen Pharmaceutica NV,
Turnhoutseweg 30, 2340 Beerse,
BE
|
| (54) | IMIDAZOPYRAZINES AND PYRAZOLOPYRIMIDINES AND THEIR USE AS AMPA RECEPTOR MODULATORS |
| IMIDAZOPYRAZINES AND PYRAZOLOPYRIMIDINES AND THEIR USE AS AMPA RECEPTOR MODULATORS |